Efficacy and safety of venetoclax plus azacitidine for patients with treatment-naive high-risk myelodysplastic syndromesJacqueline S. Garcia, Guillermo Garcia‐Manero, Uwe Platzbecker et al.|Blood|2024Cited by 32
ALLG APML5: bioavailability and safety of oral arsenic trioxide assessed during consolidation therapy for APLHarry Iland, Andrew H. Wei, Liane Khoo et al.|Blood Advances|2025Cited by 4